Sources of diversity in T cell epitope discovery

Frontiers in Bioscience

Volumn 16, Issue 7, 2011, Pages 3014-3035

  Chang, Cynthia Xin Lei ^a   Dai, Lingyun ^a,b   Tan, Zhen Wei ^a   Choo, Joanna Ai Ling ^a   Bertoletti, Antonio ^c   Grotenbreg, Gijsbert M ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c AGENCY FOR SCIENCE   (Singapore)

Author keywords

Diversity; Epitope mapping; Immunotechnologies; Review; T cell response

Indexed keywords

EPITOPE; HLA ANTIGEN; HLA ANTIGEN CLASS 1;

AMINO ACID SEQUENCE; ANIMAL; ANTIGEN PRESENTATION; ANTIGENIC VARIATION; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGICAL PROCEDURES; IMMUNOLOGY; PROTEIN DATABASE; REVIEW; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; ANTIGENIC VARIATION; DATABASES, PROTEIN; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOLOGIC TECHNIQUES; T-LYMPHOCYTES;

EID: 79959549305     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3895     Document Type: Article

References (213)

1. MA Williams, MJ Bevan: Effector and memory CTL differentiation. Annu Rev Immunol 25, 171-192 (2007) (Pubitemid 46697906)
2. JE Smith-Garvin, GA Koretzky, MS Jordan: T cell activation. Annu Rev Immunol 27, 591-619 (2009)
3. J Nikolich-Zugich, MK Slifka, I Messaoudi: The many important facets of T-cell repertoire diversity. Nat Rev Immunol 4, 123-132 (2004) (Pubitemid 38209206)
4. SJ Turner, PC Doherty, J McCluskey, J Rossjohn: Structural determinants of T-cell receptor bias in immunity. Nat Rev Immunol 6, 883-894 (2006) (Pubitemid 44851731)
5. MG Rudolph, RL Stanfield, IA Wilson: How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol 24, 419-466 (2006)
6. V Venturi, DA Price, DC Douek, MP Davenport: The molecular basis for public T-cell responses? Nat Rev Immunol 8, 231-238 (2008) (Pubitemid 351323289)
7. JM Vyas, AG Van der Veen, HL Ploegh: The known unknowns of antigen processing and presentation. Nat Rev Immunol 8, 607-618 (2008)
8. N Shastri, S Schwab, T Serwold: Producing nature's genechips: the generation of peptides for display by MHC class I molecules. Annu Rev Immunol 20, 463-493 (2002) (Pubitemid 34293432)
9. ES Trombetta, I Mellman: Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol 23, 975-1028 (2005) (Pubitemid 40563191)
10. PE Jensen: Recent advances in antigen processing and presentation. Nat Immunol 8, 1041-1048 (2007) (Pubitemid 47423752)
11. RD Fleischmann, MD Adams, O White, RA Clayton, EF Kirkness, AR Kerlavage, CJ Bult, JF Tomb, BA Dougherty, JM Merrick: Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269, 496-512 (1995)
12. CW Fuller, LR Middendorf, SA Benner, GM Church, T Harris, X Huang, SB Jovanovich, JR Nelson, JA Schloss, DC Schwartz, DV Vezenov: The challenges of sequencing by synthesis. Nat Biotechnol 27, 1013-1023 (2009)
13. J Shendure, H Ji: Next-generation DNA sequencing. Nat Biotechnol 26, 1135-1145 (2008)
14. IN Okeke, J Wain: Post-genomic challenges for collaborative research in infectious diseases. Nat Rev Microbiol 6, 858-864 (2008)
15. BW Wren: Microbial genome analysis: insights into virulence, host adaptation and evolution. Nat Rev Genet 1, 30-39 (2000)
16. R Zhang, CT Zhang: The impact of comparative genomics on infectious disease research. Microbes Infect 8, 1613-1622 (2006) (Pubitemid 43903309)
17. N Salimi, W Fleri, B Peters, A Sette: Design and utilization of epitope-based databases and predictive tools. Immunogenetics 62, 185-196 (2010)
18. HG Rammensee, T Friede, S Stevanoviíc: MHC ligands and peptide motifs: first listing. Immunogenetics 41, 178-228 (1995)
19. H Rammensee, J Bachmann, NP Emmerich, OA Bachor, S Stevanović: SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50, 213-219 (1999) (Pubitemid 30099526)
20. IS Yang, JY Lee, JS Lee, WP Mitchell, HB Oh, C Kang, KH Kim: Influenza sequence and epitope database. Nucleic Acids Res 37, D423-430 (2009)
21. C Kuiken, B Korber, RW Shafer: HIV sequence databases. AIDS Rev 5, 52-61 (2003) (Pubitemid 36873895)
22. JC Tong, L Kong, TW Tan, S Ranganathan: MPID-T: database for sequence-structure-function information on Tcell receptor/peptide/MHC interactions. Appl Bioinformatics 5, 111-114 (2006) (Pubitemid 43846020)
23. V Davies, K Vaughan, R Damle, B Peters, A Sette: Classification of the universe of immune epitope literature: representation and knowledge gaps. PLoS ONE 4, e6948 (2009)
24. R Vita, L Zarebski, JA Greenbaum, H Emami, I Hoof, N Salimi, R Damle, A Sette, B Peters: The immune epitope database 2.0. Nucleic Acids Res 38, D854-862 (2010)
25. E Lafuente, P Reche: Prediction of MHC-Peptide Binding: A Systematic and Comprehensive Overview. Curr Pharm Des 15, 3209-3220 (2009)
26. JC Tong, EC Ren: Immunoinformatics: Current trends and future directions. Drug Discov Today 14, 684-689 (2009)
27. JC Tong, TW, Tan, S Ranganathan: Methods and protocols for prediction of immunogenic epitopes. Brief Bioinform 8, 96-108 (2007) (Pubitemid 47072260)
28. C Lundegaard, O Lund, S Buus, M Nielsen: Major histocompatibility complex class I binding predictions as a tool in epitope discovery. Immunology 130, 309-318 (2010)
29. K Falk, O Rötzschke, S Stevanović, G Jung, HG Rammensee: Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351, 290-296 (1991) (Pubitemid 21896578)
30. HH Lin, S Ray, S Tongchusak, EL Reinherz, V Brusic: Evaluation of MHC class I peptide binding prediction servers: applications for vaccine research. BMC Immunol 9, 8 (2008)
31. B Peters, HH Bui, S Frankild, M Nielson, C Lundegaard, E Kostem, D Basch, K Lamberth, M Harndahl, W Fleri, SS Wilson, J Sidney, O Lund, S Buus, A Sette: A community resource benchmarking predictions of peptide binding to MHC-I molecules. PLoS Comput Biol 2, e65 (2006)
32. H Zhang, C Lundegaard, M Nielsen: Pan-specific MHC class I predictors: a benchmark of HLA class I pan-specific prediction methods. Bioinformatics 25, 83-89 (2009)
33. JW Yewdell, HD Hickman: New lane in the information highway: alternative reading frame peptides elicit T cells with potent antiretrovirus activity. J Exp Med 204, 2501-2504 (2007) (Pubitemid 350044774)
34. O Ho, WR Green: Alternative translational products and cryptic T cell epitopes: expecting the unexpected. J Immunol 177, 8283-8289 (2006) (Pubitemid 44893787)
35. J Ireland, J Herzog, ER Unanue: Cutting edge: unique T cells that recognize citrullinated peptides are a feature of protein immunization. J Immunol 177, 1421-1425 (2006) (Pubitemid 44092474)
36. N Shastri, S Cardinaud, SR Schwab, T Serwold, J Kunisawa: All the peptides that fit: the beginning, the middle, and the end of the MHC class I antigen-processing pathway. Immunol Rev 207, 31-41 (2005) (Pubitemid 41415006)
37. PF Robbins, M El-Gamil, YF Li, EB Fitzgerald, Y Kawakami, SA Rosenberg: The intronic region of an incompletely spliced gp100 gene transcript encodes an epitope recognized by melanoma-reactive tumor-infiltrating lymphocytes. J Immunol 159, 303-308 (1997) (Pubitemid 127493713)
38. PG Coulie, F Lehmann, B Lethé, J Herman, C Lurquin, M Andrawiss, T Boon: A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc Natl Acad Sci USA 92, 7976-7980 (1995)
39. A Uenaka, Y Hirano, H Hata, S Win, T Aji, M Tanaka, T Ono, JCA Skipper, K Shimizu, E Nakayama: Cryptic CTL epitope on a murine sarcoma Meth A generated by exon extension as a novel mechanism. J Immunol 170, 4862-4868 (2003) (Pubitemid 36519998)
40. TN Bullock, LC Eisenlohr: Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading frames. J Exp Med 184, 1319-1329 (1996) (Pubitemid 26354688)
41. TN Bullock, AE Patterson, LL Franlin, E Notidis, LC Eisenlohr: Initiation codon scanthrough versus termination codon readthrough demonstrates strong potential for major histocompatibility complex class I-restricted cryptic epitope expression. J Exp Med 186, 1051-1058 (1997) (Pubitemid 27441149)
42. S Malarkannan, T Horng, PP Shih, S Schwab, N Shastri: Presentation of out-of-frame peptide/MHC class I complexes by a novel translation initiation mechanism. Immunity 10, 681-690 (1999) (Pubitemid 29302921)
43. SR Schwab, KC Li, C Kang, N Shastri: Constitutive display of cryptic translation products by MHC class I molecules. Science 301, 1367-1371 (2003) (Pubitemid 37075810)
44. N Shastri, V Nguyen, F Gonzalez: Major histocompatibility class I molecules can present cryptic translation products to T-cells. J Biol Chem 270, 1088-1091 (1995)
45. A Uenaka, T Ono, T Akisawa, H Wada, T Yasuda, E Nakayama: Identification of a unique antigen peptide pRL1 on BALB/c RL male 1 leukemia recognized by cytotoxic T lymphocytes and its relation to the Akt oncogene. J Exp Med 180, 1599-1607 (1994) (Pubitemid 24328552)
46. I Saeterdal, J Bjørheim, K Lislerud, MK Gjertsen, IK Bukholm, OC Olsen, JM Nesland, JA Eriksen, M Møller, A Lindblom, G Gaudernack: Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer. Proc Natl Acad Sci USA 98, 13255-13260 (2001) (Pubitemid 33051349)
47. X Saulquin, E Scotet, L Trautmann, MA Peyrat, F Halary, M Bonneville, E Houssaint: +1 Frameshifting as a novel mechanism to generate a cryptic cytotoxic T lymphocyte epitope derived from human interleukin 10. J Exp Med 195, 353-358 (2002) (Pubitemid 34461493)
48. CT Berger, JM Carlson, CJ Brumme, KL Hartman, ZL Brumme, LM Henry, PC Rosato, A Piechocka-Trocha, MA Brockman, PR Harrigan, D Heckerman, DE Kaufmann, C Brander: Viral adaptation to immune selection pressure by HLA class I-restricted CTL responses targeting epitopes in HIV frameshift sequences. J Exp Med 207, 61-75 (2010)
49. S Cardinaud, A Moris, M Février, PS Rohrlich, L Weiss, P Langlade-Demoyen, FA Lemonnier, O Schwartz, A Habel: Identification of cryptic MHC I-restricted epitopes encoded by HIV-1 alternative reading frames. J Exp Med 199, 1053-1063 (2004) (Pubitemid 38619902)
50. CT Walsh, S Garneau-Tsodikova, GJ Gatto: Protein posttranslational modifications: the chemistry of proteome diversifications. Angew Chem Int Ed Engl 44, 7342-7372 (2005) (Pubitemid 41689988)
51. SM Anderton: Post-translational modifications of self antigens: implications for autoimmunity. Curr Opin Immunol 16, 753-758 (2004) (Pubitemid 39423665)
52. VH Engelhard, M Altrich-Vanlith, M Ostankovitch, AL Zarling: Post-translational modifications of naturally processed MHC-binding epitopes. Curr Opin Immunol 18, 92-97 (2006) (Pubitemid 43049654)
53. J Petersen, AW Purcell, J Rossjohn: Post-translationally modified T cell epitopes: immune recognition and immunotherapy. J Mol Med 87, 1045-1051 (2009)
54. J Yagüe, I Alvarez, D Rognan, M Ramos, J Vázquez, JA de Castro: An N-acetylated natural ligand of human histocompatibility leukocyte antigen (HLA)-B39. Classical major histocompatibility complex class I proteins bind peptides with a blocked NH(2) terminus in vivo. J Exp Med 191, 2083-2092 (2000) (Pubitemid 30416355)
55. L Meadows, W Wang, JM den Haan, E Blokland, C Reinhardus, JW Drijfhout, J Shabanowitz, R Pierce, AI Agulnik, CE Bishop, DF Hunt, E Goulmy, VH Engelhard: The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. Immunity 6, 273-281 (1997) (Pubitemid 27148594)
56. PE Van den Steen, P Proost, DD Brand, AH Kang, J Van Damme, G Opdenakker: Generation of glycosylated remnant epitopes from human collagen type II by gelatinase B. Biochemistry 43, 10809-10816 (2004) (Pubitemid 39096723)
57. J Yagüe, J Vázquez, JA López de Castro: A posttranslational modification of nuclear proteins, N(G),N(G)-dimethyl-Arg, found in a natural HLA class I peptide ligand. Protein Sci 9, 2210-2217 (2000) (Pubitemid 32104157)
58. J Herzog, Y Maekawa, TP Cirrito, BS Illian, ER Unanue: Activated antigen-presenting cells select and present chemically modified peptides recognized by unique CD4 T cells. Proc Natl Acad Sci USA 102, 7928-7933 (2005) (Pubitemid 40781040)
59. MJ van Stipdonk, AA Willems, S Amor, C Persoon-Deen, PJ Travers, CJ Boog, JM van Noort: T cells discriminate between differentially phosphorylated forms of alphaBcrystallin, a major central nervous system myelin antigen. Int Immunol 10, 943-950 (1998) (Pubitemid 28325610)
60. SN McAdam, B Fleckenstein, IB Rasmussen, DG Schmid, I Sandlie, B Bogen, NJ Viner, LM Sollid: T cell recognition of the dominant I-A(k)-restricted hen egg lysozyme epitope: critical role for asparagine deamidation. J Exp Med 193, 1239-1246 (2001) (Pubitemid 32524774)
61. JC Skipper, RC Hendrickson, PH Gulden, V Brichard, A Van Pel, Y Chen, J Shabanowitz, T Wolfel, CL Slingluff, T Boon, DF Hunt, VH Engelhard: An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins. J Exp Med 183, 527-534 (1996) (Pubitemid 26059516)
62. L Cao, R Goodin, D Wood, MA Moscarello, JN Whitaker: Rapid release and unusual stability of immunodominant peptide 45-89 from citrullinated myelin basic protein. Biochemistry 38, 6157-6163 (1999)
63. W Chen, NJ Ede, DC Jackson, J Mccluskey, AW Purcell: CTL recognition of an altered peptide associated with asparagine bond rearrangement. Implications for immunity and vaccine design. J Immunol 157, 1000-1005 (1996)
64. SI Mannering, LC Harrison, NA Williamson, JS Morris, DJ Thearle, KP Jensen, TWH Kay, J Rossjohn, BA Falk, GT Nepom, AW Purcell: The insulin A-chain epitope recognized by human T cells is posttranslationally modified. J Exp Med 202, 1191-1197 (2005) (Pubitemid 41586950)
65. JA Hill, S Southwood, A Sette, AM Jevnikar, DA Bell, E Cairns: Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol 171, 538-541 (2003) (Pubitemid 36871358)
66. H Arentz-Hansen, R Körner, O Molberg, H Quarsten, W Vader, YM Kooy, KE Lundin, F Koning, P Roepstorff, LM Sollid, SN McAdam: The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med 191, 603-612 (2000)
67. CX Moss, SP Matthews, DJ Lamont, C Watts: Asparagine deamidation perturbs antigen presentation on class II major histocompatibility complex molecules. J Biol Chem 280, 18498-18503 (2005) (Pubitemid 41389099)
68. CR Berkers, A de Jong, H Ovaa, B Rodenko: Transpeptidation and reverse proteolysis and their consequences for immunity. Int J Biochem Cell Biol 41, 66-71 (2009)
69. H Paulus: Protein splicing and related forms of protein autoprocessing. Annu Rev Biochem 69, 447-496 (2000)
70. V Muralidharan, TW Muir: Protein ligation: an enabling technology for the biophysical analysis of proteins. Nat Methods 3, 429-438 (2006) (Pubitemid 43811554)
71. KI Hanada, JW Yewdell, JC Yang: Immune recognition of a human renal cancer antigen through post-translational protein splicing. Nature 427, 252-256 (2004) (Pubitemid 38112041)
72. N Vigneron, V Stroobant, J Chapiro, A Ooms, G Degiovanni, S Morel, P van der Bruggen, T Boon, BJ Van den Eynde: An antigenic peptide produced by peptide splicing in the proteasome. Science 304, 587-590 (2004) (Pubitemid 38541917)
73. EH Warren, NJ Vigneron, MA Gavin, PG Coulie, V Stroobant, A Dalet, SS Tykodi, SM Xuereb, JK Mito, SR Riddell, BJ Van den Eynde: An antigen produced by splicing of noncontiguous peptides in the reverse order. Science 313, 1444-1447 (2006) (Pubitemid 44360274)
74. T Shiina, K Hosomichi, H Inoko, JK Kulski: The HLA genomic loci map: expression, interaction, diversity and disease. J Hum Genet 54, 15-39 (2009)
75. R Horton, L Wilming, V Rand, RC Lovering, EA Bruford, VK Khodiyar, MJ Lush, S Povey, CC Talbot Jr, MW Wright, HM Wain, J Trowsdale, A Ziegler, S Beck: Gene map of the extended human MHC. Nat Rev Genet 5, 889-899 (2004) (Pubitemid 39564252)
76. RM Zinkernagel, PC Doherty: Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 248, 701-702 (1974)
77. P Hraber, C Kuiken, K Yusim: Evidence for human leukocyte antigen heterozygote advantage against hepatitis C virus infection. Hepatology 46, 1713-1721 (2007)
78. MR Thursz, HC Thomas, BM Greenwood, AV Hill: Heterozygote advantage for HLA class-II type in hepatitis B virus infection. Nat Genet 17, 11-12 (1997)
79. M Carrington, GW Nelson, MP Martin, T Kissner, D Vlahov, JJ Goedert, R Kaslow, S Buchbinder, K Hoots, SJ O'Brien: HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 283, 1748-1752 (1999)
80. http://www.ebi.ac.uk/imgt/hla/stats.html
81. OD Solberg, SJ Mack, AK Lancaster, RM Single, Y Tsai, A Sanchez-Mazas, G Thomson: Balancing selection and heterogeneity across the classical human leukocyte antigen loci: a meta-analytic review of 497 population studies. Hum Immunol 69, 443-464 (2008)
82. www.ncbi.nlm.nih.gov/gv/mhc/main.cgi
83. HA Stephens: HLA and other gene associations with dengue disease severity. Curr Top Microbiol Immunol 338, 99-114 (2010)
84. M Carrington, SJ O'Brien: The influence of HLA genotype on AIDS. Annu Rev Med 54, 535-551 (2003) (Pubitemid 37386411)
85. Y Ghodke, K Joshi, A Chopra, B Patwardhan: HLA and disease. Eur J Epidemiol 20, 475-488 (2005) (Pubitemid 40933924)
86. AT Tan, E Loggi, C Boni, A Chia, AJ Gehring, KS Sastry, V Goh, P Fisicaro, P Andreone, C Brander, SG Lim, C Ferrari, F Bihl, A Bertoletti: Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire. J Virol 82, 10986-10997 (2008)
87. M Martin, M Carrington: Immunogenetics of viral infections. Curr Opin Immunol 17, 510-516 (2005) (Pubitemid 41207955)
88. J Sidney, M del Guercio, S Southwood, V Engelhard, E Appella, H Rammensee, K Falk, O Rötzschke, M Takiguchi, R Kubo: Several HLA alleles share overlapping peptide specificities. J Immunol 154, 247-259 (1995)
89. J Sidney, H Grey, R Kubo, A Sette: Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. Immunol Today 17, 261-266 (1996) (Pubitemid 26183489)
90. DH Fremont, M Matsumura, EA Stura, PA Peterson, IA Wilson: Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. Science 257, 919-927 (1992)
91. HC Guo, TS Jardetzky, TP Garrett, WS Lane, JL Strominger, DC Wiley: Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle. Nature 360, 364-366 (1992) (Pubitemid 23000678)
92. DR Madden, JC Gorga, JL Strominger, DC Wiley: The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC. Cell 70, 1035-1048 (1992)
93. M Matsumura, DH Fremont, PA Peterson, IA Wilson: Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 257, 927-934 (1992)
94. MA Saper, PJ Bjorkman, DC Wiley: Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. J Mol Biol 219, 277-319 (1991)
95. A Sette, J Sidney: Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 50, 201-212 (1999) (Pubitemid 30099525)
96. J Sidney, B Peters, N Frahm, C Brander, A Sette: HLA class I supertypes: a revised and updated classification. BMC Immunol 9, 1 (2008)
97. F Klug, M Miller, HH Schmidt, S Stevanović: Characterization of MHC ligands for peptide based tumor vaccination. Curr Pharm Des 15, 3221-3236 (2009)
98. M Provenzano, MC Panelli, S Mocellin, L Bracci, G Sais, DF Stroncek, GC. Spagnoli, FM Marincola: MHCpeptide specificity and T-cell epitope mapping: where immunotherapy starts. Trends Mol Med 12, 465-472 (2006) (Pubitemid 44441999)
99. G Li Pira, F Ivaldi, P Moretti, F Manca: High throughput T epitope mapping and vaccine development. J Biomed Biotechnol 2010, 325720 (2010)
100. R Buchli, RS Vangundy, CF Giberson, WH Hildebrand: Critical factors in the development of fluorescence polarization-based peptide binding assays: an equilibrium study monitoring specific peptide binding to soluble HLA-A*0201. J Immunol Methods 314, 38-53 (2006) (Pubitemid 44189427)
101. M Harndahl, S Justesen, K Lamberth, G Røder, M Nielsen, S Buus: Peptide binding to HLA class I molecules: homogenous, high-throughput screening, and affinity assays. J Biomol Screen 14, 173-180 (2009)
102. W Chen, S Khilko, J Fecondo, DH Margulies, J McCluskey: Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues. J Exp Med 180, 1471-1483 (1994)
103. TN Schumacher, MT Heemels, JJ Neefjes, WM Kast, CJ Melief, HL Ploegh: Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro. Cell 62, 563-567 (1990)
104. NA Hosken, MJ Bevan: Defective presentation of endogenous antigen by a cell line expressing class I molecules. Science 248, 367-370 (1990)
105. JH Kessler, B Mommaas, T Mutis, I Huijbers, D Vissers, WE Benckhuijsen, GMT Schreuder, R Offringa, E Goulmy, CJM Melief, SH van der Burg, JW Drijfhout: Competition-based cellular peptide binding assays for 13 prevalent HLA class I alleles using fluorescein-labeled synthetic peptides. Hum Immunol 64, 245-255 (2003) (Pubitemid 36197353)
106. SH van der Burg, MJ Visseren, RM Brandt, WM Kast, CJ Melief: Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. J Immunol 156, 3308-3314 (1996) (Pubitemid 26123546)
107. EL Huczko, WM Bodnar, D Benjamin, K Sakaguchi, NZ Zhu, J Shabanowitz, RA Henderson, E Appella, DF Hunt, VH Engelhard: Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling. J Immunol 151, 2572-2587 (1993) (Pubitemid 23264510)
108. M del Guercio, J Sidney, G Hermanson, C Perez, H Grey, R Kubo, A Sette: Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J Immunol 154, 685-693 (1995)
109. F Boisgérault, V Tieng, MC Stolzenberg, N Dulphy, I Khalil, R Tamouza, D Charron, A Toubert: Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies. J Clin Invest 98, 2764-2770 (1996)
110. HJ Zeh, GH Leder, MT Lotze, RD Salter, M Tector, G Stuber, S Modrow, WJ Storkus: Flow-cytometric determination of peptide-class I complex formation. Identification of p53 peptides that bind to HLA-A2. Hum Immunol 39, 79-86 (1994)
111. A Bertoletti, A Costanzo, FV Chisari, M Levrero, M Artini, A Sette, A Penna, T Giuberti, F Fiaccadori, C Ferrari: Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J Exp Med 180, 933-943 (1994) (Pubitemid 24256606)
112. R Bertoni, J Sidney, P Fowler, R Chesnut, F Chisari, A Sette: Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. J Clin Invest 100, 503-513 (1997) (Pubitemid 27340496)
113. A Sette, J Sidney, MF del Guercio, S Southwood, J Ruppert, C Dahlberg, HM Grey, RT Kubo: Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays. Mol Immunol 31, 813-822 (1994) (Pubitemid 24254672)
114. AC Olsen, LO Pedersen, AS Hansen, MH Nissen, M Olsen, PR Hansen, A Holm, S Buus: A quantitative assay to measure the interaction between immunogenic peptides and purified class I major histocompatibility complex molecules. Eur J Immunol 24, 385-392 (1994) (Pubitemid 24041129)
115. J Ruppert, J Sidney, E Celis, RT Kubo, HM Grey, A Sette: Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 74, 929-937 (1993) (Pubitemid 23270612)
116. GM Grotenbreg, MJ Nicholson, KD Fowler, K Wilbuer, L Octavio, M Yang, AK Chakraborty, HL Ploegh, KW Wucherpfennig: Empty Class II Major Histocompatibility Complex Created by Peptide Photolysis Establishes the Role of DM in Peptide Association. J Biol Chem 282, 21425-21436 (2007) (Pubitemid 47099928)
117. C Sylvester-Hvid, N Kristensen, T Blicher, H Ferre, SL Lauemoller, XA Wolf, K Lamberth, MH Nissen, LO Pedersen, S Buus: Establishment of a quantitative ELISA capable of determining peptide - MHC class I interaction. Tissue Antigens 59, 251-258 (2002)
118. SR Hadrup, M Toebes, B Rodenko, AH Bakker, DA Egan, H Ovaa, TN Schumacher: High-throughput T-cell epitope discovery through MHC peptide exchange. Methods Mol Biol 524, 383-405 (2009)
119. K Udaka, TJ Tsomides, HN Eisen: A naturally occurring peptide recognized by alloreactive CD8+ cytotoxic T lymphocytes in association with a class I MHC protein. Cell 69, 989-998 (1992)
120. AL Cox, J Skipper, Y Chen, RA Henderson, TL Darrow, J Shabanowitz, VH Engelhard, DF Hunt, CL Slingluff Jr: Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science 264, 716-719 (1994) (Pubitemid 24185883)
121. M Schirle, W Keilholz, B Weber, C Gouttefangeas, T Dumrese, HD Becker, S Stevanovic, HG Rammensee: Identification of tumor-associated MHC class I ligands by a novel T cell-independent approach. Eur J Immunol 30, 2216-2225 (2000) (Pubitemid 30655761)
122. K Antwi, PD Hanavan, CE Myers, YW Ruiz, EJ Thompson, DF Lake: Proteomic identification of an MHCbinding peptidome from pancreas and breast cancer cell lines. Mol Immunol 46, 2931-2937 (2009)
123. S Hofmann, M Gluckmann, S Kausche, A Schmidt, C Corvey, R Lichtenfels, C Huber, C Albrecht, M Karas, W Herr: Rapid and sensitive identification of major histocompatibility complex class I-associated tumor peptides by Nano-LC MALDI MS/MS. Mol Cell Proteomics 4, 1888-1897 (2005) (Pubitemid 41830183)
124. HD Hickman, AD Luis, R Buchli, SR Few, M Sathiamurthy, RS VanGundy, CF Giberson, WH Hildebrand: Toward a definition of self: proteomic evaluation of the class I peptide repertoire. J Immunol 172, 2944-2952 (2004) (Pubitemid 38263681)
125. JD Altman, PA Moss, PJ Goulder, DH Barouch, MG McHeyzer-Williams, JI Bell, AJ McMichael, MM Davis: Phenotypic analysis of antigen-specific T lymphocytes. Science 274, 94-96 (1996) (Pubitemid 26332731)
126. DSJ Allan, EJM Lepin, VM Braud, CA O'Callaghan, AJ McMichael: Tetrameric complexes of HLA-E, HLA-F, and HLA-G. J Immunol Methods 268, 43-50 (2002) (Pubitemid 35223107)
127. AH Bakker, TNM Schumacher: MHC multimer technology: current status and future prospects. Curr Opin Immunol 17, 428-433 (2005) (Pubitemid 40848547)
128. L Wooldridge, A Lissina, DK Cole, HA van den Berg, DA Price, AK Sewell: Tricks with tetramers: how to get the most from multimeric peptide-MHC. Immunology 126, 147-164 (2009)
129. M Toebes, M Coccoris, A Bins, B Rodenko, R Gomez, NJ Nieuwkoop, W van de Kasteele, GF Rimmelzwaan, JBAG Haanen, H Ovaa, TNM Schumacher: Design and use of conditional MHC class I ligands. Nat Med 12, 246-251 (2006) (Pubitemid 43214754)
130. B Rodenko, M Toebes, SR Hadrup, WJ van Esch, AM Molenaar, TN Schumacher, H Ovaa: Generation of peptide-MHC class I complexes through UV-mediated ligand exchange. Nat Protoc 1, 1120-1132 (2006)
131. B Rodenko, M Toebes, PH Celie, A Perrakis, TN Schumacher, H Ovaa: Class I major histocompatibility complexes loaded by a periodate trigger. J Am Chem Soc 131, 12305-12313 (2009)
132. S Gredmark-Russ, EJ Cheung, MK Isaacson, HL Ploegh, GM Grotenbreg: The CD8 T-cell response against murine gammaherpesvirus 68 is directed toward a broad repertoire of epitopes from both early and late antigens. J Virol 82, 12205-12212 (2008)
133. GM Grotenbreg, NR Roan, E Guillen, R Meijers, JH Wang, GW Bell, MN Starnbach, HL Ploegh: Discovery of CD8+ T cell epitopes in Chlamydia trachomatis infection through use of caged class I MHC tetramers. Proc Natl Acad Sci USA 105, 3831-3836 (2008) (Pubitemid 351723485)
134. DC Wilson, GM Grotenbreg, K Liu, Y Zhao, EM Frickel, MJ Gubbels, HL Ploegh, GS Yap: Differential Regulation of Effector-and Central-Memory Responses to Toxoplasma gondii Infection by IL-12 Revealed by Tracking of Tgd057-Specific CD8+ T Cells. PLoS Pathog 6, e1000815 (2010)
135. EM Frickel, N Sahoo, J Hopp, MJ Gubbels, MPJ Craver, LJ Knoll, HL Ploegh, GM Grotenbreg: Parasite Stage-Specific Recognition of Endogenous Toxoplasma gondii-Derived CD8 +T Cell Epitopes. J Infect Dis 198, 1625-1633 (2008)
136. AH Bakker, R Hoppes, C Linnemann, M Toebes, B Rodenko, CR Berkers, SR Hadrup, WJE van Esch, MHM Heemskerk, H Ovaa, TNM Schumacher: Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7. Proc Natl Acad Sci USA 105, 3825-3830 (2008) (Pubitemid 351723484)
137. SR Hadrup, AH Bakker, CJ Shu, RS Andersen, J van Veluw, P Hombrink, E Castermans, P Thor Straten, C Blank, JB Haanen, MH Heemskerk, TN Schumacher: Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers. Nat Methods 6, 520-526 (2009)
138. EW Newell, LO Klein, W Yu, MM Davis: Simultaneous detection of many T-cell specificities using combinatorial tetramer staining. Nat Methods, 6, 497-499 (2009)
139. CE Lewis: Detecting cytokine production at the single-cell level. Cytokine 3, 184-188 (1991)
140. F Kern, IP Surel, C Brock, B Freistedt, H Radtke, A Scheffold, R Blasczyk, P Reinke, J Schneider-Mergener, A Radbruch, P Walden, HD Volk: T-cell epitope mapping by flow cytometry. Nat Med 4, 975-978 (1998)
141. AW Sylwester, BL Mitchell, JB Edgar, C Taormina, C Pelte, F Ruchti, PR Sleath, KH Grabstein, NA Hosken, F Kern, JA Nelson, LJ Picker: Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med 202, 673-685 (2005) (Pubitemid 41248418)
142. T Jung, U Schauer, C Heusser, C Neumann, C Rieger: Detection of intracellular cytokines by flow cytometry. J Immunol Methods 159, 197-207 (1993)
143. LJ Picker, MK Singh, Z Zdraveski, JR Treer, SL Waldrop, PR Bergstresser VC Maino: Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 86, 1408-1419 (1995)
144. C Prussin, DD Metcalfe: Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. J Immunol Methods, 188, 117-128 (1995) (Pubitemid 26011539)
145. B Foster, C Prussin, F Liu, JK Whitmire, JL Whitton: Detection of intracellular cytokines by flow cytometry. Curr Protoc Immunol Chapter 6, Unit 6 24 (2007)
146. MR Betts, JM Brenchley, DA Price, SC De Rosa, DC Douek, M Roederer, RA Koup: Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 281, 65-78 (2003) (Pubitemid 37324571)
147. M Wolfl, J Kuball, WY Ho, H Nguyen, TJ Manley, M Bleakley, PD Greenberg: Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities. Blood 110, 201-210 (2007) (Pubitemid 47026836)
148. AJ Zajac, JN Blattman, K Murali-Krishna, DJ Sourdive, M Suresh, JD Altman, R Ahmed: Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 188, 2205-2213 (1998) (Pubitemid 29028493)
149. JM Benson, KA Campbell, Z Guan, IE Gienapp, SS Stuckman, T Forsthuber, CC Whitacre: T-cell activation and receptor downmodulation precede deletion
150. BA Mehta, VC Maino: Simultaneous detection of DNA synthesis and cytokine production in staphylococcal enterotoxin B activated CD4+ T lymphocytes by flow cytometry. J Immunol Methods 208, 49-59 (1997) (Pubitemid 28018368)
151. J Michalek, RH Collins, BJ Hill, JM Brenchley, DC Douek: Identification and monitoring of graft-versus-host specific T-cell clone in stem cell transplantation. Lancet 361, 1183-1185 (2003) (Pubitemid 36398389)
152. DW Houck, MR Loken: Simultaneous analysis of cell surface antigens, bromodeoxyuridine incorporation and DNA content. Cytometry, 6, 531-538 (1985) (Pubitemid 16257683)
153. J McGill, KL Legge: Cutting edge: contribution of lungresident T cell proliferation to the overall magnitude of the antigen-specific CD8 T cell response in the lungs following murine influenza virus infection. J Immunol 183, 4177-4181 (2009)
154. AB Lyons, CR Parish: Determination of lymphocyte division by flow cytometry. J Immunol Methods 171, 131-137 (1994) (Pubitemid 24140219)
155. J Mintern, M Li, GM Davey, E Blanas, C Kurts, FR Carbone, WR Heath: The use of carboxyfluorescein diacetate succinimidyl ester to determine the site, duration and cell type responsible for antigen presentation in vivo. Immunol Cell Biol 77, 539-543 (1999)
156. O Kirak, EM Frickel, GM Grotenbreg, H Suh, R Jaenisch, HL Ploegh: Transnuclear mice with predefined T cell receptor specificities against Toxoplasma gondii obtained via SCNT. Science 328, 243-248 (2010)
157. PK Chattopadhyay, CM Hogerkorp, M Roederer: A chromatic explosion: the development and future of multiparameter flow cytometry. Immunology, 125, 441-449 (2008)
158. ML Precopio, MR Betts, J Parrino, DA Price, E Gostick, DR Ambrozak, TE Asher, DC Douek, A Harari, G Pantaleo, R Bailer, BS Graham, M Roederer, RA Koup: Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses. J Exp Med 204, 1405-1416 (2007) (Pubitemid 46919878)
159. PK Wallace, JD Tario Jr, JL Fisher, SS Wallace, MS Ernstoff, KA Muirhead: Tracking antigen-driven responses by flow cytometry: monitoring proliferation by dye dilution. Cytometry A 73, 1019-1034 (2008)
160. JM Versteegen, T Logtenberg, RE Ballieux: Enumeration of IFN-gamma-producing human lymphocytes by spot-ELISA. A method to detect lymphokine-producing lymphocytes at the single-cell level. J Immunol Methods, 111, 25-29 (1988)
161. C Czerkinsky, G Andersson, HP Ekre, LA Nilsson, L Klareskog, O Ouchterlony: Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells. J Immunol Methods 110, 29-36 (1988)
162. M Wulf, P Hoehn, P Trinder: Identification and validation of T-cell epitopes using the IFN-gamma ELISPOT assay. Methods Mol Biol 524, 439-446 (2009)
163. J Wen, Z Duan, L Jiang: Identification of a dengue virusspecific HLA-A*0201-restricted CD8+ T cell epitope. J Med Virol 82, 642-648 (2010)
164. LE Yauch, RM Zellweger, MF Kotturi, A Qutubuddin, J Sidney, B Peters, TR Prestwood, A Sette, S Shresta: A protective role for dengue virus-specific CD8+ T cells. J Immunol 182, 4865-4873 (2009)
165. CK Li, H Wu, H Yan, S Ma, L Wang, M Zhang, X Tang, NJ Temperton, RA Weiss, JM Brenchley, DC Douek, J Mongkolsapaya, BH Tran, CL Lin, GR Screaton, JL Hou, AJ McMichael, XN Xu: T cell responses to whole SARS coronavirus in humans. J Immunol 181, 5490-5500 (2008)
166. R Manz, M Assenmacher, E Pfluger, S Miltenyi, A Radbruch: Analysis and sorting of live cells according to secreted molecules, relocated to a cell-surface affinity matrix. Proc Natl Acad Sci U S A 92, 1921-1925 (1995)
167. H Brosterhus, S Brings, H Leyendeckers, RA Manz, S Miltenyi, A Radbruch, M Assenmacher, J Schmitz: Enrichment and detection of live antigen-specific CD4(+) and CD8(+) T cells based on cytokine secretion. Eur J Immunol 29, 4053-4059 (1999)
168. JD Campbell: Detection and enrichment of antigenspecific CD4+ and CD8+ T cells based on cytokine secretion. Methods 31, 150-159 (2003) (Pubitemid 37075900)
169. MJ Pittet, A Zippelius, DE Speiser, M Assenmacher, P Guillaume, D Valmori, D Lienard, F Lejeune, JC Cerottini P Romero: Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseases. J Immunol 166, 7634-7640 (2001) (Pubitemid 32525646)
170. M Assenmacher, M Lohning, A Scheffold, RA Manz, J Schmitz, A Radbruch: Sequential production of IL-2, IFNgamma and IL-10 by individual staphylococcal enterotoxin Bactivated T helper lymphocytes. Eur J Immunol 28, 1534-1543 (1998) (Pubitemid 28221156)
171. M Oelke, T Kurokawa, I Hentrich, D Behringer, V Cerundolo, A Lindemann, A Mackensen: Functional characterization of CD8(+) antigen-specific cytotoxic T lymphocytes after enrichment based on cytokine secretion: comparison with the MHC-tetramer technology. Scand J Immunol 52, 544-549 (2000) (Pubitemid 32011766)
172. G Rauser, H Einsele, C Sinzger, D Wernet, G Kuntz, M Assenmacher, JD Campbell, MS Topp: Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants. Blood 103, 3565-3572 (2004) (Pubitemid 38525695)
173. G Li Pira, F Ivaldi, G Tripodi, M Martinengo, F Manca: Positive selection and expansion of cytomegalovirus-specific CD4 and CD8 T cells in sealed systems: potential applications for adoptive cellular immunoreconstitution. J Immunother 31, 762-770 (2008)
174. M Oelke, U Moehrle, JL Chen, D Behringer, V Cerundolo, A Lindemann, A Mackensen: Generation and purification of CD8+ melan-A-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy. Clin Cancer Res 6, 1997-2005 (2000) (Pubitemid 30306176)
175. DM McKinney, R Skvoretz, M Qin, G Ishioka, A Sette: Characterization of an in situ IFN-gamma ELISA assay which is able to detect specific peptide responses from freshly isolated splenocytes induced by DNA minigene immunization. J Immunol Methods 237, 105-117 (2000) (Pubitemid 30139507)
176. G Li Pira, F Ivaldi, L Bottone, F Manca: High throughput functional microdissection of pathogen-specific T-cell immunity using antigen and lymphocyte arrays. J Immunol Methods 326, 22-32 (2007) (Pubitemid 47361195)
177. G Li Pira, F Ivaldi, C Dentone, E Righi, V Del Bono, C Viscoli, G Koopman, F Manca: Evaluation of antigen-specific T-cell responses with a miniaturized and automated method. Clin Vaccine Immunol 15, 1811-1818 (2008)
178. M Provenzano, S Mocellin, P Bonginelli, D Nagorsen, SW Kwon, D Stroncek: Ex vivo screening for immunodominant viral epitopes by quantitative real time polymerase chain reaction (qRT-PCR). J Transl Med 1, 12 (2003)
179. JB Lim, M Provenzano, OH Kwon, M Bettinotti, L Caruccio, D Nagorsen, D Stroncek: Identification of HLAA33-restricted CMV pp65 epitopes as common targets for CD8(+) CMV-specific cytotoxic T lymphocytes. Exp Hematol 34, 296-307 (2006)
180. DS Chen, Y Soen, TB Stuge, PP Lee, JS Weber, PO Brown, MM Davis: Marked differences in human melanoma antigen-specific T cell responsiveness after vaccination using a functional microarray. PLoS Med 2, e265 (2005)
181. G Deviren, K Gupta, ME Paulaitis, JP Schneck: Detection of antigen-specific T cells on p/MHC microarrays. J Mol Recognit 20, 32-38 (2007) (Pubitemid 46160158)
182. Y Soen, DS Chen, DL Kraft, MM Davis, PO Brown: Detection and characterization of cellular immune responses using peptide-MHC microarrays. PLoS Biol 1, E65 (2003)
183. JD Stone, WE Demkowicz Jr, LJ Stern: HLArestricted epitope identification and detection of functional T cell responses by using MHC-peptide and costimulatory microarrays. Proc Natl Acad Sci U S A, 102, 3744-3749 (2005) (Pubitemid 40354682)
184. GA Kwong, CG Radu, K Hwang, CJ Shu, C Ma, RC Koya, B Comin-Anduix, SR Hadrup, RC Bailey, ON Witte, TN Schumacher, A Ribas, JR Heath: Modular nucleic acid assembled p/MHC microarrays for multiplexed sorting of antigen-specific T cells. J Am Chem Soc 131, 9695-9703 (2009)
185. CM Britten, C Gouttefangeas, MJP Welters, G Pawelec, S Koch, C Ottensmeier, A Mander, S Walter, A Paschen, J Müller-Berghaus, I Haas, A Mackensen, T Køllgaard, P thor Straten, M Schmitt, K Giannopoulos, R Maier, H Veelken, C Bertinetti, A Konur, C Huber, S Stevanović, T Wölfel, SH van der Burg: The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays. Cancer Immunol Immunother 57, 289-302 (2008) (Pubitemid 350295380)
186. CM Britten, S Janetzki, L Ben-Porat, TM Clay, M Kalos, H Maecker, K Odunsi, M Pride, L Old, A Hoos, P Romero, HLA-peptide Multimer Proficiency Panel of the CVC-CRI Immune Assay Working Group: Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium. Cancer Immunol Immunother 58, 1701-1713 (2009)
187. JW Gratama, M Boeckh, R Nakamura, JJ Cornelissen, RA Brooimans, JA Zaia, SJ Forman, K Gaal, KR Bray, GH Gasior, CS Boyce, LA Sullivan, PC Southwick: Immune monitoring with iTAgTM MHC tetramers for prediction of recurrent or persistent cytomegalovirus (CMV) infection or disease in allogeneic hematopoietic stem cell transplant (HCT) recipients: a prospective multicenter study. Blood 116, 1655-1662 (2010)
188. S Janetzki, KS Panageas, L Ben-Porat, J Boyer, CM Britten, TM Clay, M Kalos, HT Maecker, P Romero, J Yuan, WM Kast, A Hoos, Elispot Proficiency Panel of the CVC Immune Assay Working Group: Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI). Cancer Immunol Immunother 57, 303-315 (2008) (Pubitemid 350295382)
189. S Janetzki, L Price, CM Britten, SH van der Burg, J Caterini, JR Currier, G Ferrari, C Gouttefangeas, P Hayes, E Kaempgen, V Lennerz, K Nihlmark, V Souza, A Hoos: Performance of serum-supplemented and serum-free media in IFNgamma Elispot Assays for human T cells. Cancer Immunol Immunother 59, 609-618 (2010)
190. A Mander, C Gouttefangeas, C Ottensmeier, MJP Welters, L Low, SH Burg, CM Britten: Serum is not required for ex vivo IFN-γ ELISPOT: a collaborative study of different protocols from the European CIMT Immunoguiding Program. Cancer Immunol Immunother 59, 619-627 (2010)
191. HT Maecker, JP Mccoy Jr, FOCIS Human Immunophenotyping Consortium, M Amos, J Elliott, A Gaigalas, L Wang, R Aranda, J Banchereau, C Boshoff, J Braun, Y Korin, E Reed, J Cho, D Hafler, M Davis, CG Fathman, W Robinson, T Denny, K Weinhold, B Desai, B Diamond, P Gregersen, P Dimeglio, F Nestle, M Peakman, F Villnova, J Ferbas, E Field, A Kantor, T Kawabata, W Komocsar, M Lotze, J Nepom, H Ochs, R O'Lone, D Phippard, S Plevy, S Rich, M Roederer, D Rotrosen, JH Yeh: A model for harmonizing flow cytometry in clinical trials. Nat Immunol 11, 975-978 (2010)
192. A Brazma, P Hingamp, J Quackenbush, G Sherlock, P Spellman, C Stoeckert, J Aach, W Ansorge, CA Ball, HC Causton, T Gaasterland, P Glenisson, FC Holstege, IF Kim, V Markowitz, JC Matese, H Parkinson, A Robinson, U Sarkans, S Schulze-Kremer, J Stewart, R Taylor, J Vilo, M, Vingron: Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 29, 365-371 (2001) (Pubitemid 34326681)
193. S Janetzki, CM Britten, M Kalos, HI Levitsky, HT Maecker, CJM Melief, LJ Old, P Romero, A Hoos, MM Davis: "MIATA"-minimal information about T cell assays. Immunity 31, 527-528 (2009)
194. www.miataproject.org
195. M Bull, D Lee, J Stucky, YL Chiu, A Rubin, H Horton, MJ McElrath: Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials. J Immunol Methods 322, 57-69 (2007) (Pubitemid 46560582)
196. LS Kierstead, S Dubey, B Meyer, TW Tobery, R Mogg, VR Fernandez, R Long, L Guan, C Gaunt, K Collins, KJ Sykes, DV Mehrotra, N Chirmule, JW Shiver, DR Casimiro: Enhanced rates and magnitude of immune responses detected against an HIV vaccine: effect of using an optimized process for isolating PBMC. AIDS Res Hum Retroviruses 23, 86-92 (2007) (Pubitemid 46214176)
197. CR Kreher, MT Dittrich, R Guerkov, BO Boehm, M Tary-Lehmann: CD4+ and CD8+ cells in cryopreserved human PBMC maintain full functionality in cytokine ELISPOT assays. J Immunol Methods 278, 79-93 (2003) (Pubitemid 37281194)
198. HT Maecker, J Moon, S Bhatia, SA Ghanekar, VC Maino, JK Payne, K Kuus-Reichel, JC Chang, A Summers, TM Clay, MA Morse, HK Lyerly, C DeLaRosa, DP Ankerst, ML Disis: Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT. BMC Immunol 6, 17 (2005)
199. JG Smith, HR Joseph, T Green, JA Field, M Wooters, RM Kaufhold, J Antonello, MJ Caulfield: Establishing acceptance criteria for cell-mediated-immunity assays using frozen peripheral blood mononuclear cells stored under optimal and suboptimal conditions. Clin Vaccine Immunol 14, 527-537 (2007)
200. SG Smith, SA Joosten, V Verscheure, AA Pathan, H McShane, THM Ottenhoff, HM Dockrell, F Mascart: Identification of major factors influencing ELISpot-based monitoring of cellular responses to antigens from Mycobacterium tuberculosis. PLoS ONE 4, e7972 (2009)
201. JH Cox, G Ferrari, SA Kalams, W Lopaczynski, N Oden, MP D'souza, ECS Group: Results of an ELISPOT proficiency panel conducted in 11 laboratories participating in international human immunodeficiency virus type 1 vaccine trials. AIDS Res Hum Retroviruses 21, 68-81 (2005) (Pubitemid 40179803)
202. S Dubey, J Clair, TM Fu, L Guan, R Long, R Mogg, K Anderson, KB Collins, C Gaunt, VR Fernandez, L Zhu, L Kierstead, S Thaler, SB Gupta, W Straus, D Mehrotra, TW Tobery, DR Casimiro, JW Shiver: Detection of HIV vaccine-induced cell-mediated immunity in HIVseronegative clinical trial participants using an optimized and validated enzyme-linked immunospot assay. J Acquir Immune Defic Syndr 45, 20-27 (2007) (Pubitemid 46684439)
203. MG Hudgens, SG Self, YL Chiu, ND Russell, H Horton, MJ McElrath: Statistical considerations for the design and analysis of the ELISpot assay in HIV-1 vaccine trials. J Immunol Methods 288, 19-34 (2004) (Pubitemid 38739249)
204. Z Moodie, Y Huang, L Gu, J Hural, SG Self: Statistical positivity criteria for the analysis of ELISpot assay data in HIV-1 vaccine trials. J Immunol Methods 315, 121-132 (2006) (Pubitemid 44419512)
205. AJ McMichael, P Borrow, GD Tomaras, N Goonetilleke, BF Haynes: The immune response during acute HIV-1 infection: clues for vaccine development. Nat Rev Immunol 10, 11-23 (2010)
206. BD Walker, DR Burton: Toward an AIDS vaccine. Science 320, 760-764 (2008) (Pubitemid 351929619)
207. DH Barouch: Challenges in the development of an HIV-1 vaccine. Nature 455, 613-619 (2008)
208. S Gaudieri, A Rauch, L Park, E Freitas, S Herrmann, G Jeffrey, W Cheng, K Pfafferott, K Naidoo, R Chapman, M Battegay, R Weber, A Telenti, H Furrer, I James, M Lucas, S Mallal: Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection. J Virol 80, 11094-11104 (2006) (Pubitemid 44706550)
209. C Moore, M John, I James, F Christiansen, C Witt, S Mallal: Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 296, 1439-1443 (2002) (Pubitemid 34553083)
210. P de Campos-Lima, R Gavioli, Q Zhang, L Wallace, R Dolcetti, M Rowe, A Rickinson, M Masucci: HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population. Science 260, 98-100 (1993) (Pubitemid 23122753)
211. AT Tan, S Koh, V Goh, A Bertoletti: Understanding the immunopathogenesis of chronic hepatitis B virus: An Asian prospective. J Gastroenterol Hepatol 23, 833-843 (2008) (Pubitemid 351806581)
212. F Prugnolle, A Manica, M Charpentier, J Guégan, V Guernier, F Balloux: Pathogen-driven selection and worldwide HLA class I diversity. Curr Biol 15, 1022-1027 (2005) (Pubitemid 40772149)
213. M Moutaftsi, B Peters, V Pasquetto, DC Tscharke, J Sidney, HH Bui, H Grey, A Sette: A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus. Nat Biotechnol 24, 817-819 (2006) (Pubitemid 44086622)